The Series B round was led by N47 with participation from Felicis, Northzone, Gradient, and Italian Founders Fund.
"Every other enterprise software category has been transformed by AI, but the tools managing the world’s largest workforce are still fundamentally the same systems that were built 20 years ago. We had a ten-year plan. AI made it a one-year plan"
The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.
"During their time at Imperial, they worked in one of the pioneering research groups that invented modern glucose strip technology. Their combined expertise in electrochemistry, biosensing, and medical device engineering laid the foundation for Sava’s next-generation biosensor platform."